FairJourney CEO Hire: Next-Gen AI Sales Trigger

🚀 Battle Card: FairJourney Biologics S.A.

• Dr. Werner Lanthaler, Chief Executive Officer · 🔗 [LinkedIn](https://www.linkedin.com/company/fairjourney-biologics/)

• New CEO with proven track record at Evotec signals push for data- and AI-driven efficiency—classic FairJourney Biologics S.A. sales trigger for pipeline acceleration. → Source

• Aligning scalable, data-driven platforms to accelerate antibody discovery

• Reducing development timelines and costs amid competitive biotech landscape

• Primary: AI-driven discovery platform → Accelerate "Gene to Clone" cycles by 30%

• Expansion: Global collaboration portal → Enhance partner engagement & data sharing

• HQ: Porto, Portugal

• Employees: ≈ 200

• Rev: ≈ $45 M

• Website: [fjbio.com](https://fjbio.com/)

🤼 Competitive Intel

• charlesriver.com — Antibody discovery & preclinical services
• Unique edge: End-to-end CRO scale & regulatory expertise
• Evaluated by VP R&D for capability breadth

• evotec.com — Integrated drug discovery platform
• Unique edge: AI-driven precision medicine pipelines
• Evaluated by CSO for innovation potential

• abzena.com — Biologics development CRO
• Unique edge: Modular, flexible capacity with rapid scale-up
• Evaluated by Dir. Bioprocess for timeline adherence

• domainex.co.uk — Drug discovery & medicinal chemistry
• Unique edge: Specialized small molecule & bispecific antibody design
• Evaluated by VP Discovery for custom chemistry support

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑❑
OFFER_BRIEF   = ❑❑
PROOF_METRIC  = ❑❑
CTA_STYLE     = ❑❑
TONE          = ❑❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Werner
COMPANY     = FairJourney Biologics S.A.
DEPT        = R&D
SIZE        = ≈50
BOTTLENECK  = scaling data-driven discovery platform
EVENT       = New CEO appointment
DETAIL      = Appointment of Dr. Werner Lanthaler as CEO
PAIN        = reducing development timelines and costs
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20251007049277&div=41152219
SIM_CO      = Evotec
WIN_METRIC  = 30% faster discovery cycles
NEXT_SIZE   = ≈100
EMP_EST     = ≈200
REV_EST     = ≈$45M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈50-person R&D

Werner—noticed your R&D team is ≈50.

That’s when scaling data-driven discovery platform slows growth.

We helped Evotec fix this with .

Result: 30% faster discovery cycles.  
Quick call?

PS—next bottleneck hits ≈100.

DM ≤45 words, TONE:
Saw your post about Appointment of Dr. Werner Lanthaler as CEO — reducing development timelines and costs.  
. .  
Quick chat?```